On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Talk outline
- Known facts about NK cell development (1993)
- IL-2 and IL-15 receptors
- IL-15 induces human NK cell differentiation
- Factors responsible for NK cells development
- KL/FL ligands and NK cells development (1)
- KL/FL ligands and NK cells development (2)
- SCF, IL-2 and IL-15 in NK cell development
- Human natural killer cell development
- Which CD34 subset develops into a NK cell?
- CD34 receptor expression
- CD34 in peripheral blood and lymph nodes
- NK precursor selectively enriched in lymph nodes
- Site of NK cell development
- NK cells in lymph nodes are CD56 bright cells
- Putative stages of human NK cell differentiation
- NK cell development in human lymphopoiesis
- IL-15 and human NK cell survival
- Adoptive transfer of NK cells
- IL-15 is required for NK cell survival in vivo
- IL-15 and NK cell development and survival
- The IL-15 transgene
- NK cell expansion in IL-15tg mice
- IL-15tg mice clinical signs and findings
- Acute T-NK lymphoblastic leukemia
- NK cell maturation
- NK cell subsets
- The immunoregulatory role of NK cell subsets
- Where does the INF-gamma signal come from?
- Macrophage and NK co-culture: LPS activation (1)
- NK cell-derived IFN-gamma
- Macrophage and NK co-culture: LPS activation (2)
- Bright cells are the primary source of IFN-gamma
- IFN-gamma production in bright and dim cells
- CD56 bright NK cells in the immune response
- Innate immunoregulator, CD56 bright
- Innate cytotoxic effector, CD56 dim
- How do inhibitory NKR work? (1)
- How does KIR work?
- How do Inhibitory NKR work? (2)
- The inhibitory receptors bind to specific epitopes
- Common epitopes that bind to these receptors
- Haplo-mismatch bone marrow transplant (BMT)
- Haplo-mismatch BMT that results in lysis
- Haplo-mismatch BMT that results in no lysis
- Haplo-mismatch BMT - no lysis outcome
- Summary of haplo-mismatch BMT
- KIR mismatch/ no mismatch
- Conclusions
- Summary
- Acknowledgments
Topics Covered
- Human NK cell development
- What factors are responsible for NK cell development?
- How does KL or FL assist IL-15 in NK cell development?
- NK progenitor, NK precursor, mature NK cell
- Only CD34dimCD45RA(+) HPC differentiate into CD56bright NK cells
- NK cells are in human lymph nodes and are CD56bright
- Putative stages of human NK cell differentiation in nodes/tonsils
- How NK cell development fits in human lymphopoiesis
- IL-15 and human NK cell survival
- Adoptive transfer of NK cells into IL-15-deficient mice
- IL-15 transgene
- Lymphoblastic leukemia
- Human NK cell subsets
- Do NK cell subsets have unique immunoregulatory roles?
- LPS activation
- NK cell-derived IFN-γ in the innate immune response
- Innate immunoregulator, CD56bright
- Innate cytotoxic effector, CD56dim
- How do inhibitory NKR work?
- How does KIR work?
- Haplo-mismatch BMT
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Caligiuri, M. (2009, September 23). Natural killer cells: development, diversity and applications to human disease [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/OXWK2452.Export Citation (RIS)
Publication History
- Published on September 23, 2009
Financial Disclosures
- Prof. Mike Caligiuri has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Hide